Human Orthohantavirus disease prevalence and genotype distribution in the U.S., 2008-2020: a retrospective observational studyResearch in context

• Main Authors: Shannon L.M. Whitmer (Author), Amy Whitesell (Author), Melissa Mobley (Author), Emir Talundzic (Author), Elizabeth Shedroff (Author), Caitlin M. Cossaboom (Author), Sharon Messenger (Author), Mojgan Deldari (Author), Julu Bhatnagar (Author), Lindsey Estetter (Author), Sara Zufan (Author), Debi Cannon (Author), Cheng-Feng Chiang (Author), Ardith Gibbons (Author), Inna Krapiunaya (Author), Maria Morales-Betoulle (Author), Mary Choi (Author), Barbara Knust (Author), Brian Amman (Author), Joel M. Montgomery (Author), Trevor Shoemaker (Author), John D. Klena (Author)
• Format: Book
• Published: Elsevier, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: In the United States (U.S.), hantavirus pulmonary syndrome (HPS) and non-HPS hantavirus infection are nationally notifiable diseases. Criteria for identifying human cases are based on clinical symptoms (HPS or non-HPS) and acute diagnostic results (IgM+, rising IgG+ titers, RT-P...